Boyd Graves petitions U.S. Supreme Court for 'full disclosure' of secret AIDS program

No.________ In The SUPREME COURT OF THE UNITED STATES October Term 2008 BOYD ED GRAVES, ET. AL., Petitioners, Vs. UNITED STATES OF AMERICA, ET. AL. Respondents. On petition for Writ of Certiorari to the United States Court of Appeals for the Ninth Circuit Case No. 07-56782 PETITION FOR WRIT OF CERTIORARI NOW COMES petitioner, Boyd Ed Graves, on behalf of the American people, who seeks an answer to the following question: “Did the U.S. Attorney General receive “Service” of the complaint seeking “full disclosure” of the U.S. Special Virus Cancer Program?” Petitioner raises this question to the Court in an attempt to seek accountability of the U.S. Special Virus Cancer Program (1962 – 1978). It is commonly believed this federal virus development program lies at the heart of the genesis and etiology of HIV/AIDS. Petitioner believes the issue of the ORIGIN of AIDS is one of the most significant issues affecting mankind to date. The public significance of this case requires the Court to grant a writ of certiorari in that the further security of our homeland is at issue. The U.S. Constitution affords an inalienable right to life and as such provides the jurisdiction for this petition to be heard. Petitioner has been afflicted with HIV/AIDS for sixteen years and has come to find there was a federal virus development program that preceded the onset of HIV/AIDS. When petitioner sought ‘disclosure’ of the federal program UNDER THE Freedom of Information Act (FOIA), the lower court ruled that petitioner had ‘failed to serve’ the U.S. Attorney General and dismissed the case without prejudice. When petitioner filed the “new” (second) complaint, the lower court dismissed it outright and the Ninth Circuit affirmed via mandate. The lower court erred when it overlooked a “RETURN RECEIPT” from the U.S. Attorney General showing “service” on May 15, 2007. See, EXHIBIT 1, herein. The return receipt confirms the U.S. Attorney General has been aware of the “solid evidence” of a federal virus development program for well over a year, and has taken no action of his own accord as the country’s top law enforcement officer. Petitioner prays the high Court will grant a writ of certiorari to begin the long and troubling process of rectifying the social ills of a federal program outside the dominion of the United States Constitution. The eventual “full disclosure” of the U.S. Special Virus Cancer Program will ultimately change and save the people of the world. Respectfully submitted, Boyd Ed Graves 3593 Fifth Avenue, Suite D San Diego, Ca. 92103 619-849-9364 Certificate of Service I, Boyd Ed Graves, Do hereby certify with my signature below that I served a true copy of this petition on the following via first class mail, postage prepaid to: President George W. Bush c/o Michael B. Mukasey U.S. Attorney General 950 Pennsylvania Avenue Washington, D.C. 20530 Sent this ____day of September, 2008 _________________________ Boyd Ed Graves

Boyd Graves asks Congressman Filner investigate formerly secret AIDS program

San Diego – Yesterday U.S.Congressman Bob Filner (D-Ca) received a presentation by American humanrights activist and HIV/AIDS advocate Dr. Boyd E. Graves on the formerly secret U.S. Special Virus Program's 1971 Research Logic Flowchart and the evidence of the laboratory birth of AIDS.

“We have now reconnected the U.S. Congress to our position from prior to9-11. Congressman Filner took a 40 minute presentation that seemed like an hour and a half,” Graves said. “The evidence proves a federal virus development program preceded the onset of HIV/AIDS.HIV/AIDS is the Synthetic Biological Agent funded by Congress on June9, 1969 and May 1946.”

Graves, a lawyer and researcher in San Diego, has recovered over 15 years of 'missing' medical evidenced titled the U.S. Special Virus Cancer Program (1962-1978). The progress reports of the virus development program detail every contract and laboratory experiment towards creating HIV/AIDS,according to Graves and a plethora of international scientific and medical experts familiar with the documents. Graves is considered one of the leading researchers on the topic.

“The secret program's 1971 'research logic' flowchart proves to a level of 'absolute evidence', the design, purpose and intent of this secret federal program, the U.S. Special Virus program,” Graves said. “Any National AIDS Strategy must incorporate the immediate clinical trials of the U.S. eleven year oldpatented Cure for AIDS, U.S. patent#5676977, www.uspto.gov.”

Following the dismissal of his last Freedom of Information Act litigation in federal court, Dr. Graves said he will re-file. Dr. Graves has been lead plaintiff in multiple lawsuits against the formerly secret federal program since the discovery of the flow chart document in 1999. Each lawsuit has been quietly dismissed from the courts and some court records.

“To date no one can offer an answer as to when the visna virus crossed species. This point will prove to show further problematic for the United States,” Graves said. “We can immensely improve the treatment for HIV/AIDS, and at the same time create a healthy, happy environment for victims of this federal program.”

Congressman Bob Filner is an eighth term Democrat from California 51st District elected in 1992 and a super-delegate pledged to Barack Obama. Dr. Boyd Graves is a vocal human rights' activist and the first African American to receive the U.S. Patented AIDS Cure, Tetrasil. Graves is the author of two books,“STATE ORIGIN: The Evidence of the Laboratory Birth of AIDS,” and“WORLD WAR AIDS: The Third World War.”

###

photo: Congressman Bob Filner with Dr. Boyd Graves June 30, 2008. photo by Benjamin Martin, Yesterday Magazine.

FDA Warns Companies Importing and Marketing Drugs Over the Internet that Fraudulently Claim to Prevent and Treat STDs

FDA News

FOR IMMEDIATE RELEASE
March 6, 2008


Media Inquiries:
Rita Chappelle, 301-827-6242
Consumer Inquiries:
888-INFO-FDA

FDA Warns Companies Importing and Marketing Drugs Over the Internet that Fraudulently Claim to Prevent and Treat STDs

The U.S. Food and Drug Administration today issued Warning Letters to six U.S. companies and one foreign individual for marketing unapproved and misbranded drugs over the Internet to U.S. consumers for the prevention and treatment of sexually transmitted diseases (STDs).

Some of these products, directed at U.S. consumers, falsely claim to have "FDA Approval" and some claim to be "more effective" than conventional medicine. The products are sold as Tetrasil, Genisil, Aviralex, OXi-MED, Imulux, Beta-mannan, Micronutrient, Qina, and SlicPlus. Consumers who are currently using these products should stop their use immediately and consult their health care professional if they have experienced any adverse effects that they suspect are related to the use of any of these products.

"The products pose a serious health threat to unsuspecting consumers who don’t know that these products are not FDA approved and have not been proven safe or effective," said Janet Woodcock, M.D., deputy commissioner for scientific and medical programs, chief medical officer, and acting director of the FDA’s Center for Drug Evaluation and Research. "STDs are very serious diseases and these products give consumers a false sense of security that they are protected from STDs."

The products claim to prevent or treat a variety of STDs, including Herpes, Chlamydia, Human Papilloma Virus, cervical dysplasia, and HIV/AIDS. The FDA considers these U.S. and imported products to be unapproved new drugs being marketed in violation of the Federal Food, Drug and Cosmetic Act. They are also misbranded under the law because they lack proper directions for use by consumers. In addition, some of the products are misbranded because they make false and misleading claims.

Examples of claims that these products make include "Treatment Kills all Herpes Viruses WITHOUT having to use conventional drugs or medications," "Greatest STD Protection Without Condoms," (SlicPlus) and "The active ingredient in our product is FDA certified to destroy 99.9992 percent of all pathogenic organisms [ie] Chlamydia" (OXi-MED).

The Warning Letters inform the companies that failure to properly resolve violations of the law may cause them to face further enforcement action that can include seizure of illegal products, injunction, and possible criminal prosecution.

Issuing these Warning Letters is part of the FDA’s ongoing campaign against fraudulent products marketed on the Internet for serious and life-threatening diseases. The agency also works to educate consumers about the risks and dangers that exist from buying unsafe products.

Consumers and health care professionals should notify the FDA of any complaints or problems associated with these products. These reports may be made to MedWatch, the FDA’s voluntary reporting program, by calling 800-FDA-1088, or electronically at www.fda.gov/medwatch/report.htm.

To view the letters,
http://www.fda.gov/foi/warning_letters/s6680c.htm - Aviralex Int.

http://www.fda.gov/foi/warning_letters/s6681c.htm - Aidance Skincare

http://www.fda.gov/foi/warning_letters/s6682c.htm - Health-science-report

http://www.fda.gov/foi/warning_letters/s6683c.htm - NeumaLife

http://www.fda.gov/foi/warning_letters/s6684c.htm - IMULUX, LLC

http://www.fda.gov/foi/warning_letters/s6685c.htm - Saferex Laboratories

http://www.fda.gov/foi/warning_letters/s6686c.htm - McKinnon, Blair

#